New Orleans, LA – June 2026 — New Orleans is set to become the center of the diabetes research world this June 5th–8th as the American Diabetes Association's 86th Scientific Sessions welcomes more than 12,000 experts from across the globe. Biopharma Informatic is proud to be counted among the attendees at this landmark event, where the latest breakthroughs, research findings and innovations in diabetes care are expected to be introduced and evaluated by leading experts in the field.
The urgency behind these conversations is hard to ignore. Nearly one in nine adults worldwide is now living with diabetes and of those, an estimated 252 million have no idea they have the condition. Against this backdrop, Biopharma Informatic will be attending this year’s American Diabetes Association, where discussions will span everything from early prevention science to late-stage clinical trial data. The event is expected to be as broad and complex as the disease itself, offering attendees meaningful insights to take back into their work.
At Biopharma Informatic, diabetes research has been a core part of our clinical work for a reason. The careful patient selection, the coordination and the stakes involved, these are things we understand well and a commitment to doing them right is something we stand behind. It is meetings like the American Diabetes Association that make the pace of progress in diabetes research feel very real and very present.
This year, Khaula Raza, MSN, NP-C, Sub-Investigator, will be representing Biopharma Informatic throughout the event, engaging with the clinical research community on the ground. If you're attending and a conversation feels right — whether about trial opportunities, a potential partnership, or simply what's happening in the field, we'd be glad to hear from you.
Reach out at [email protected] to schedule time in New Orleans.
For more information, visit www.biopharmainfo.net
Biopharma Informatic
Phone: (281) 944-3610
Email: [email protected]